Award recordCONTRACT

CSL BEHRING L.L.C.

PIID 36C26119F0205· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $175,542 net obligations· UEI H3WKVE9VBLY3· PA

Description

HAEGARDA 3000MG/VIAL

First action · last action
2019-02-01 · 2020-06-04
Transactions
2
First transaction's obligation
$200,619
Base + all options value (sum of deltas)
$175,542
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$200,619$0Base award · 2019-02-01 · this action $200,619 · running total $200,619Modification P00001 · 2020-06-04 · this action -$25,077 · running total $175,542
  • Base2019-02-01+$200,619= $200,619
  • Mod P000012020-06-04-$25,077= $175,542
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-02-01+$200,619$200,619HAEGARDA 3000MG/VIAL
Mod P00001· FUNDING ONLY ACTION2020-06-04−$25,077$175,542HAEGARDA 3000MG/VIAL

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26119F0205_3600_V797D50358_3600 · retrieved 2026-09-26.